Jun Mao of the Perelman School of Medicine is highlighted for leading research on high-dose capsules of chamomile.
Perelman School of Medicine
This weekend, Penn hosted the first Ivy Plus Symposium and workshops for diverse scholars, a national conference designed to encourage exceptional undergraduate students to pursue advanced training in the sciences, technology, engineering and mathematics, or STEM, fields.
PHILADELPHIA — A new study from a team of researchers at the Perelman School of Medicine at the University of Pennsylvania, the Monell Chemical Senses Center, and the Philadelphia VA Medical Center, reveals that a person’s ability to taste certain bitter flavors is directly related to their ability to fight off upper respiratory tract infections, specifically chronic sinus infections. The new research is published in the latest edition of the Journ
Daniel Rader of the Perelman School of Medicine comments on patients who develop heart disease at a young age.
PHILADELPHIA — Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
PHILADELPHIA — A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S.
PHILADELPHIA — LAM, short for pulmonary lymphangioleiomyomatosis, affects about 1 in 10,000 women of childbearing age and is characterized by proliferation of smooth muscle-like cells in the lung, destruction of lung tissue, and growth of lymphatic vessels. The disease is caused by inactivation of either of two genes, TSC1 or TSC2, but to date no animal model has been able to replicate the pathologic features those mutations produce in humans.
Lee Sweeney of the Perelman School of Medicine comments on the results of a new experimental drug used with muscular dystrophy.